Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more ...
Fagundes, MD, discussed when proton therapy is most justified over photon approaches in prostate cancer. In an interview with ...
A new study revealed molecular features linked to more aggressive prostate cancer in a subset of patients who had been ...
Tampere University Hospital (Tays) has begun offering a new form of radiotherapy to treat rectal cancer in which a high dose ...
PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.
Two New Studies Highlight the Dynamic Meaning of PSA After Prostate Cancer Treatment / Abdenour Nabid, Alison C. Tree, Almudena Zapatero, Amar ...
Adding aglatimagene besadenovec (CAN-2409) to external beam radiation therapy (EBRT) was associated with greater lymphocyte infiltration of prostate tissue and greater lymphocyte- ...
August–September 2026 / bladder cancer, cancer, cancer care, Cancer research, cancer treatment, chemotherapy, clinical trials ...
Fagundes, MD, discussed disease control by risk group among 404 patients with prostate cancer treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results